MCRB

SERES THERAPEUTICS INC

MCRB·81750R201·US·Common Stock·Healthcare - Biotechnology-13D/G

MCRB (SERES THERAPEUTICS INC) is held by 25 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($2.6M), MARSHALL WACE, LLP ($1.2M), Vontobel Holding Ltd. ($1.2M). Net institutional sentiment: Mixed.

25
Holders
Avg rating(5 Elite)
$9.9M
Total Value
48% (31)
Fund Consensus
13 buying - 14 selling
MCRBSmart Money Verdict
View all
Held by 25 funds
5 elite
Who's Trading
InsiderBKBrady KellySell $444.27May 18, 2026
InsiderSDShaff Eric D.Sell $2KFeb 15, 2026
InsiderYLYoung Teresa L.Sell $635.25Feb 15, 2026
InsiderDTDesRosier ThomasSell $660.66Feb 15, 2026
InsiderHRHenn Matthew RSell $753.83Feb 15, 2026
InsiderSDShaff Eric D.Sell $4KNov 15, 2025
InsiderYLYoung Teresa L.Sell $18KNov 15, 2025
InsiderDTDesRosier ThomasSell $1KNov 15, 2025
InsiderHRHenn Matthew RSell $22KNov 15, 2025
ActivistFMR LLCFMR LLC3.1%Aug 6, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
294,143$2.6M0.0%-30.57%
36
Increased
139,539(+16.1%)$1.2M0.0%-45.96%
29
Increased
138,468(+34.1%)$1.2M0.0%-59.34%
33
Decreased
105,339(-41.5%)$934,3570.0%-57.69%
0
Decreased
102,026(-1.5%)$904,9700.0%-63.20%
0
Decreased
74,835(-13.1%)$664,1080.0%-94.64%
0
Increased
62,316(+283.0%)$552,7430.0%-40.52%
39
New
39,643$351,6330.0%-30.57%
33
Unchanged
33,901$300,7020.0%-73.00%
0
Increased
31,630(+0.8%)$280,5580.0%-92.48%
16
Decreased
21,700(-13.6%)$192,4780.0%-64.08%
0
Decreased
18,794(-27.0%)$166,7030.0%-57.69%
0
Unchanged
14,765$130,9660.0%-94.70%
0
Increased
14,547(+1.3%)$129,0320.0%-64.92%
15
Increased
7,030(+66.3%)$62,3570.0%-54.45%
21
Decreased
6,507(-12.4%)$57,7170.0%-59.92%
0
Increased
3,070(+149.2%)$27,2300.0%-52.15%
21
New
1,975$17,5180.0%-30.57%
28
Increased
1,752(+0.7%)$15,5400.0%-63.10%
12
New
824$7,3090.0%-30.57%
25

Showing 1-20 of 31

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used